FMNL3 and ovarian cancer: Recently, circulating exosomal circFoxp1, whose expression is positively associated with International Federation of Gynecology and Obstetrics stage, primary tumor size, lymphatic metastasis, distant metastasis, residual tumor diameter, and clinical response, has been reported to promote resistance to DDP of ovarian cancer cells through up-regulating expression of CCAAT enhancer binding protein gamma (CEBPG) and formin like 3 (FMNL3) through miR-22 and miR-150-3p (Luo and Gui, 2020).